RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare a 2 immunosuppressant regimen for the treatment of
relapsing or refractory necrotizing antineutrophil cytoplasmic antibody (ANCA) associated
vasculitides.